Evidence map›Paper›PMID 19359426›Full record

ArticleAmerican journal of physiology. Gastrointestinal and liver physiology2009

Endogenous IGF-I and alpha v beta3 integrin ligands regulate increased smooth muscle growth in TNBS-induced colitis.

Krystina B Hazelgrove, Robert S Flynn, Li-Ya Qiao, John R Grider, John F Kuemmerle

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Gastrointestinal and liver physiology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 24 citations in OpenAlex.

  1. Intestinal fibrosis: ready to be reversed.Current opinion in gastroenterology · 2017
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Mechanisms of smooth muscle responses to inflammation.Neurogastroenterology and motility · 2012
    Review
  14. Article
  15. Article
  16. Differential immune and genetic responses in rat models of Crohn's colitis and ulcerative colitis.American journal of physiology. Gastrointestinal and liver physiology · 2011
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Krystina B HazelgroveDepartment of Medicine, Medical College of Virginia Campus, Virginia Commonwealth Univ., PO Box 980711, Richmond, VA 23298-0711, USA.
Robert S Flynn
Li-Ya Qiao
John R Grider
John F Kuemmerle
Virginia Commonwealth University Medical Center · US

Funding

ROLE OF GUT PEPTIDES IN INTESTINAL PERISTALSISR01DK034153 · NIDDK · VIRGINIA COMMONWEALTH UNIVERSITY · PI GRIDER, JOHN R · 1987 to 2019
$5.5M
Growth and Function of Cultured Gastrointestinal MuscleR01DK049691 · NIDDK · VIRGINIA COMMONWEALTH UNIVERSITY · PI KUEMMERLE, JOHN F · 2001 to 2014
$3.6M
Neurotrophins and Neuropeptides in Colon and Bladder HypersensitivityR01DK077917 · NIDDK · VIRGINIA COMMONWEALTH UNIVERSITY · PI QIAO, LIYA · 2008 to 2016
$2.8M
Growth and Function of Cultured Gastrointestinal MuscleR56DK049691 · NIDDK · VIRGINIA COMMONWEALTH UNIVERSITY · PI KUEMMERLE, JOHN F · 2010 to 2010
$374k
Role of Gut Peptides in Intestinal PeristalsisR56DK034153 · NIDDK · VIRGINIA COMMONWEALTH UNIVERSITY · PI GRIDER, JOHN R · 2009 to 2009
$351k
ROLE OF GUT PEPTIDES IN INTESTINAL PERISTALSISR23DK034153 · NIDDK · VIRGINIA COMMONWEALTH UNIVERSITY · PI GRIDER, JOHN R · 1986 to 1986
–
GROWTH AND FUNCTION OF CULTURED GASTROINTESTINAL MUSCLER29DK049691 · NIDDK · VIRGINIA COMMONWEALTH UNIVERSITY · PI KUEMMERLE, JOHN F · 1995 to 1999
–
NIDDK NIH HHS DK077917NIDDK NIH HHS DK34153NIDDK NIH HHS DK49691
6 · The paper itself

Abstract

Endogenous insulin-like growth factor-I (IGF-I) regulates intestinal smooth muscle growth by concomitantly stimulating proliferation and inhibiting apoptosis. IGF-I-stimulated growth is augmented by the alpha(v)beta(3) integrin ligands vitronectin and fibronectin. IGF-I expression in smooth muscle is increased in both TNBS-induced colitis and Crohn's disease. We hypothesized that intestinal inflammation increased vitronectin and fibronectin expression by smooth muscle and, along with IGF-I upregulation, increased intestinal muscle growth. Intestinal smooth muscle cells were examined 7 days following the induction of TNBS-induced colitis. Although alpha(v)beta(3) integrin expression was not altered by TNBS-induced colitis, vitronectin and fibronectin levels were increased by 80 +/- 10% and 90 +/- 15%, above control levels, respectively. Basal IGF-I receptor phosphorylation in inflamed muscle from TNBS-treated rats was increased by 86 +/- 8% over vehicle-treated controls. Basal ERK1/2, p70S6 kinase, and GSK-3beta phosphorylation in muscle cells of TNBS-treated rats were also increased by 140-180%. TNBS treatment increased basal muscle cell proliferation by 130 +/- 15% and decreased apoptosis by 20 +/- 2% compared with that in vehicle-treated controls. The changes in proliferation and apoptosis were reversed by an IGF-I receptor tyrosine kinase inhibitor or an alpha(v)beta(3) integrin antagonist. The results suggest that smooth muscle hyperplasia in TNBS-induced colitis partly results from the upregulation of endogenous IGF-I and ligands of alpha(v)beta(3) integrin that mediate increased smooth muscle cell proliferation and decreased apoptosis. This paper has identified one mechanism regulating smooth muscle hyperplasia, a feature of stricture formation that occurs in the chronically inflamed intestine of TNBS-induced colitis and potentially Crohn's disease.

Indexed as

AnimalsApoptosisCell ProliferationColitisEnzyme InhibitorsExtracellular Signal-Regulated MAP KinasesFibronectinsGlycogen Synthase Kinase 3Glycogen Synthase Kinase 3 betaHyperplasiaInsulin-Like Growth Factor IIntegrin alphaVbeta3Intercellular Signaling Peptides and ProteinsLigandsMuscle, SmoothMyocytes, Smooth MuscleechistatinEnzyme InhibitorsExtracellular Signal-Regulated MAP KinasesFibronectinsGlycogen Synthase Kinase 3Glycogen Synthase Kinase 3 betaGsk3b protein, ratInsulin-Like Growth Factor IIntegrin alphaVbeta3Intercellular Signaling Peptides and ProteinsLigandsPeptidesPhosphoinositide-3 Kinase InhibitorsRibosomal Protein S6 Kinases, 70-kDaTrinitrobenzenesulfonic AcidVitronectin

Identifiers

PMID19359426
PMCPMC2697946
OpenAlexW2123642034

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.